Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: Correlations with the three main symptoms

Journal of the Neurological Sciences

Volumn 136, Issue 1-2, 1996, Pages 169-173

  Otsuka, Makoto ^a   Ichiya, Yuichi ^b   Kuwabara, Yasuo ^b   Hosokawa, Shinichi ^b   Sasaki, Masayuki ^b   Yoshida, Tsuyoshi ^b   Fukumura, Toshimitsu ^b   Masuda, Kouji ^b   Kalo, Motohiro ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

18F Dopa uptake; Caudate and putamen; Parkinson's disease; Three main symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BRADYKINESIA; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RIGIDITY; TREMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; MIDDLE AGED; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; PATHOPHYSIOLOGY;

DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE; FLUORODOPA F 18;

ADULT; AGED; CAUDATE NUCLEUS; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUSCLE RIGIDITY; PARKINSON DISEASE; PUTAMEN; TOMOGRAPHY, EMISSION-COMPUTED; TREMOR;

EID: 0029670370     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00316-T     Document Type: Article

References (16)

1. Bernheimer, H., W. Birkmayer, O. Homykiewicz, K. Jellinger and F. Seitelberger (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci., 20: 415-455.
2. 18F-Dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann. Neurol., 28: 547-555.
3. Gamett, E.S., A.E. Lang, R. Chirakal, G. Firnau and C. Nahmias (1987) A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum. Can. J. Neurol. Sci., 14: 444-447.
4. Gibb, W.R.G. and A.J. Lees (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 54: 388-396.
5. Goto, S., A. Hirano and S. Matsumoto (1989) Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann. Neurol., 26: 766-770.
6. Hoehn, M.M. and M.D. Yahr (1967) Parkinsonism: onset, progression and mortality. Neurology, 17: 427-442.
7. Kanno, I., S. Miura, S. Yamamoto, H. Iida, M. Murakami, K. Takahashi and K. Uemura (1985) Design and evaluation of the positron emission tomograph: HEADTOME 3. J. Comput. Assist. Tomog., 9: 931-939.
8. Kish, S.J., K. Shannak and O. Hornykiewicz (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathological and clinical implications. N. Engl. J. Med., 318: 876-880.
9. Martin, W.R.W., A.J. Stoessl, M.J. Adam, W. Ammann, M. Bergstrom, R. Harrop, A. Laihinen, J.G. Rogers, T.J. Ruth, C.I. Sayre, B.D. Pate and D.B. Calne (1986) Positron emission tomography in Parkinson's disease: glucose and dopa metabolism. Adv. Neurol., 45: 95-98.
10. 18F]Fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography. J. Neurol. Sci., 115: 136-143.
11. Nahmias, C., E.S. Garnett, G. Firnau and A. Lang (1985) Striatal dopamine distribution in Parkinsonian patients during life. J. Neurol. Sci., 69: 223-230.
12. Otsuka, M., Y. Ichiya, Y. Kuwabara, Y. Miyake, T. Tahara, K. Masuda, S. Hosokawa, I. Goto, M. Kalo and A. Ichimiya (1989) Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy. Ann. Nucl. Med., 3: 111-118.
13. 18 F-Dopa uptake: difference in Parkinson's disease and atypical Parkinsonism, J. Neurol. Neurosurg. Psychiatry, 54: 898-904.
14. 18 F-dopa PET studies with or without carbidopa, Nucl. Med. Com., 14: 862-867.
15. Pifl, Ch., G. Schingnitz and O. Hornykiewicz (1988) The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Neurosci. Lett., 92: 228-233.
16. 18F]Fluorodopa studies correlate with dopamine cell counts and levels. Ann. Neurol., 34: 324-30.